Trials / Completed
CompletedNCT01913977
Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal With the Abylcap® System
Clinical Study to Determine the Optimal Operation Parameters During CO2 Removal With the Abylcap® System.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This prospective study includes 5 patients with ARDS (Acute Respiratory Distress Syndrome) treated by mechanical ventilation. In case of respiratory acidosis, extracorporeal CO2 (carbon dioxide)removal might be necessary. We hereby work with the Abylcap system with the oxygenator Lilliput2 as CO2 remover (Bellco, Italy). The patients (M/V) are older than 18, not pregnant, have a BMI\<30, and no contraindication for anticoagulation therapy. Under standard conditions patients are treated with a blood flow of QB=300mL/min and a gas flow (100% 02) of QG=7L/min. Blood sampling is performed from the arterial bloodline in the patients at 0, 1h, 3h, 24h, 48h, 72h, 96h, and 120h. A parameter study is also performed to optimise CO2 removal. Herewith, blood samples (1mL) are taken from the inlet and outlet line of the Lilliput2 at the previously mentioned time points and for different flow setting: Blood flow (QB) 200-300-400mL/min and gas flow (QG) 1.5, 3, 6, 7, 8L/min Blood samples are analysed for the different blood gases from which the extraction in the CO2 remover can be calculated for each setting of QB (blood flow) and QG (gas flow).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Abylcap® System: blood flow (QB): 200mL/min; gas flow (QG):7L/min | Abylcap settings |
| DEVICE | Abylcap® System: blood flow (QB): 300mL/min; gas flow (QG):7L/min | Abylcap settings |
| DEVICE | Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):7L/min | Abylcap settings |
| DEVICE | Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):1.5L/min | Abylcap settings |
| DEVICE | Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):3L/min | Abylcap settings |
| DEVICE | Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):6L/min | Abylcap settings |
| DEVICE | Abylcap® System: blood flow (QB): 400mL/min; gas flow (QG):8L/min | Abylcap settings |
Timeline
- Start date
- 2014-02-20
- Primary completion
- 2014-06-13
- Completion
- 2014-09-12
- First posted
- 2013-08-01
- Last updated
- 2022-12-29
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT01913977. Inclusion in this directory is not an endorsement.